These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9537233

  • 1. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A.
    Cancer Res; 1998 Apr 01; 58(7):1376-9. PubMed ID: 9537233
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K, Tommiska J, Syrjäkoski K, Kere J, Gatei M, Waddell N, Allinen M, Karppinen SM, Rapakko K, Kääriäinen H, Aittomäki K, Blomqvist C, Mustonen A, Holli K, Khanna KK, Kallioniemi OP, Nevanlinna H, Winqvist R.
    Carcinogenesis; 2007 May 01; 28(5):1040-5. PubMed ID: 17166884
    [Abstract] [Full Text] [Related]

  • 3. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.
    Breast Cancer Res Treat; 2010 Jan 01; 119(2):443-52. PubMed ID: 19404735
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH.
    Cancer Res; 2001 Oct 15; 61(20):7608-15. PubMed ID: 11606401
    [Abstract] [Full Text] [Related]

  • 5. ATM mutations in cancer families.
    Vorechovský I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM, Hammarström L.
    Cancer Res; 1996 Sep 15; 56(18):4130-3. PubMed ID: 8797579
    [Abstract] [Full Text] [Related]

  • 6. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
    Cavaciuti E, Laugé A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N.
    Genes Chromosomes Cancer; 2005 Jan 15; 42(1):1-9. PubMed ID: 15390180
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
    Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D.
    Br J Cancer; 1999 Jun 15; 80(7):1042-5. PubMed ID: 10362113
    [Abstract] [Full Text] [Related]

  • 8. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP, Bendix R, Chen P, Clark R, Dork T, Lavin MF.
    Proc Natl Acad Sci U S A; 2002 Jan 22; 99(2):925-30. PubMed ID: 11805335
    [Abstract] [Full Text] [Related]

  • 9. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer.
    Bebb DG, Yu Z, Chen J, Telatar M, Gelmon K, Phillips N, Gatti RA, Glickman BW.
    Br J Cancer; 1999 Aug 22; 80(12):1979-81. PubMed ID: 10471049
    [Abstract] [Full Text] [Related]

  • 10. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children.
    Liberzon E, Avigad S, Stark B, Zilberstein J, Freedman L, Gorfine M, Gavriel H, Cohen IJ, Goshen Y, Yaniv I, Zaizov R.
    Genes Chromosomes Cancer; 2004 Feb 22; 39(2):161-6. PubMed ID: 14695997
    [Abstract] [Full Text] [Related]

  • 11. Breast and other cancers in families with ataxia-telangiectasia.
    Swift M, Reitnauer PJ, Morrell D, Chase CL.
    N Engl J Med; 1987 May 21; 316(21):1289-94. PubMed ID: 3574400
    [Abstract] [Full Text] [Related]

  • 12. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.
    Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lönnqvist T, Kääriäinen H, Sankila R, Lähdesmäki A, Hammarström L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, Børresen-Dale AL.
    Hum Mutat; 2000 Sep 21; 16(3):232-46. PubMed ID: 10980530
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
    Swift M, Lukin JL.
    Cancer Epidemiol Biomarkers Prev; 2008 Nov 15; 17(11):3188-92. PubMed ID: 18990761
    [Abstract] [Full Text] [Related]

  • 15. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC.
    Cancer Res; 2000 Feb 15; 60(4):1062-9. PubMed ID: 10706125
    [Abstract] [Full Text] [Related]

  • 16. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA.
    Cancer Res; 2000 Aug 15; 60(16):4513-8. PubMed ID: 10969800
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
    Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF.
    Cancer Res; 1998 Aug 01; 58(15):3237-42. PubMed ID: 9699648
    [Abstract] [Full Text] [Related]

  • 18. Screening breast cancer patients for Norwegian ATM mutations.
    Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL.
    Br J Cancer; 2000 Dec 01; 83(12):1650-3. PubMed ID: 11104561
    [Abstract] [Full Text] [Related]

  • 19. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.
    BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Sep 29; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.